Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antibiotic Selection00:57

Antibiotic Selection

59.3K
Overview
59.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Repurposing Birabresib to target Gram‑positive bacteria.

npj antimicrobials and resistance·2026
Same author

Simufilam in Alzheimer's Disease: Assessment of Efficacy of a Controversial Drug in Human Neuronal Cell Culture.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Candidate orphan genes: Reassessing uniqueness.

PloS one·2025
Same author

Genome-wide identification of potassium transporters and channels in Malus domestica genome.

Scientific reports·2025
Same author

Engineering a New SsrA-Based Degradation Tag (LAA-LAA) and a Bacterial Synthetic Oscillator.

ACS synthetic biology·2025
Same author

Priestia megaterium cells are primed for surviving lethal doses of antibiotics and chemical stress.

Communications biology·2025

相关实验视频

Updated: Jan 6, 2026

Standardized Modular Assembly of Polycistronic Operons with Modular Cloning (MoClo) using the In-Cloning toolkit
06:28

Standardized Modular Assembly of Polycistronic Operons with Modular Cloning (MoClo) using the In-Cloning toolkit

Published on: September 2, 2025

601

重新使用AGI-6780激活ClpP并向格拉姆阳性细菌

Roha Razzaq1, Hazera Khatun Koly1,2, Tahmina Hossain1

  • 1Department of Biology and Microbiology, South Dakota State University, Brookings, South Dakota 57006, United States.

ACS infectious diseases
|November 10, 2025
PubMed
概括

研究人员通过向细菌ClpP蛋白酶,发现了一种新的抗微生物策略. 一种新型化合物,AGI-6780,通过过度激活ClpP,有效地杀死抗生素耐药细菌,提供了一种有前途的新疗法.

关键词:
AGI-678080 这是一本书.这就是为什么ClpPP.抗生素耐药性 抗生素耐药性抗微生物剂是一种抗微生物剂.蛋白质酶蛋白质酶是一种蛋白质.

更多相关视频

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
11:31

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa

Published on: June 30, 2016

9.1K

相关实验视频

Last Updated: Jan 6, 2026

Standardized Modular Assembly of Polycistronic Operons with Modular Cloning (MoClo) using the In-Cloning toolkit
06:28

Standardized Modular Assembly of Polycistronic Operons with Modular Cloning (MoClo) using the In-Cloning toolkit

Published on: September 2, 2025

601
Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

10.6K
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
11:31

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa

Published on: June 30, 2016

9.1K

科学领域:

  • 微生物学 微生物学
  • 药物发现 药物发现 药物发现
  • 生物化学 生化学

背景情况:

  • 抗生素耐药性病原体的增加需要新的抗菌战略.
  • 针对重要细菌过程的传统抗生素正在面临效率下降的困境.
  • 迫切需要新的抗微生物药物,具有新的作用机制.

研究的目的:

  • 识别过度激活细菌ClpP蛋白酶的小分子,作为一种新的抗菌战略.
  • 发现诱导不受控制的蛋白解导致细菌细胞死亡的化合物.
  • 探索ClpP作为一种非传统的抗菌药物开发目标.

主要方法:

  • 基于已知的ClpP-结合相互作用的高通量选.
  • 分子对接模拟用于预测结合亲和力和优先考虑化合物.
  • 在体外测试以评估抗菌活性和细胞毒性.
  • 化合物的药理动力学概况.

主要成果:

  • AGI-6780被确定为一种化合物,对ClpP活性部位具有很高的预测亲和力.
  • 在体外测试证实了AGI-6780通过向ClpP对抗格兰阳性细菌的有效性.
  • AGI-6780与利芬素的协同作用以及对人类细胞系的最小细胞毒性得到了证明.

结论:

  • AGI-6780是一种有前途的抗微生物药物,其独特的向是细菌的ClpP蛋白酶.
  • 利用ClpP提供了一种新的机制来对抗抗生素耐药的病原体.
  • 这种方法代表了开发有效抗微生物疗法的潜在新途径.